Advertisement

Global Control of Rotavirus Disease

  • Edward Kim Mulholland
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 549)

Abstract

Rotavirus was first identified by Ruth Bishop in Melbourne in 1972 (Bishop et al., 1973). Since that time it has become clear that rotavirus is a major pathogen of global public health significance, causing acute diarrhea in children often leading to dehydration which can be fatal (Parashar et al., 1998). Efforts to control the burden of rotavirus diarrhea, which mainly falls on poor children living in poor countries, have focused on three areas: environmental prevention, improvements in water, and sanitation; case management, based on provision of oral rehydration solution for children with acute diarrhea; and vaccine development. This chapter describes the available strategies and the elements of success that have been achieved thus far. The present situation regarding rotavirus control is described as well as the main barriers to progress in this field.

Keywords

Respiratory Syncytial Virus Diarrheal Disease Oral Rehydration Solution Acute Diarrhea Global Control 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barnes, G.L., Lund, J.S., Mitchell, S.V., De Bruyn, L., Piggford, L., Smith, A.L. et al. (2002). Early phase II trial of human rotavirus vaccine candidate RV3. Vaccine 20, 2950–2956.PubMedCrossRefGoogle Scholar
  2. Bernstein, D.I., Sander, D.S., Smith, V.E., Schiff, G.M., and Ward R.L. (1991). Protection from rotavirus reinfection: 2-year prospective study. J. Infect. Dis. 164, 277–283.PubMedCrossRefGoogle Scholar
  3. Bishop, R.F., Davidson, G.P., Holmes, I.H., and Ruck, R.J. (1973). Virus particles in epithelial cells of duodenal mucosa from children with acute gastroenteritis. Lancet 1, 1281–1283.CrossRefGoogle Scholar
  4. Bishop, R.F., Barnes, G.L., Cipriani, E., and Lund, J.S. (1983). Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. N. Engl. J. Med. 309, 72–76.PubMedCrossRefGoogle Scholar
  5. Cama, R.I., Parashar, U.D., Taylor, D.N., Hickey, T., Figueroa, D., Ortega, Y.R. et al. (1999). J. Infect. Dis. 179, 1139–1144.PubMedCrossRefGoogle Scholar
  6. Chanock, R., Roizman, B., and Myers, R. (1957). Recovery from infants with respiratory illness of a virus related to chimpanzee coryzal agent. Isolation, properties and characterization. Am. J. Hyg. 66, 281.PubMedGoogle Scholar
  7. Cohen, J. (2001). Rethinking a vaccine’s risk. Science 293, 1576–1577.PubMedCrossRefGoogle Scholar
  8. Davidson, G.P., Whyte, P.B.D., Daniels, E., Franklin, K., Nunan, H., McCloud, P.I. et al. (1989). Passive immunization of children with bovine colostrums containing antibodies to human rotavirus. Lancet 2, 709–712.PubMedCrossRefGoogle Scholar
  9. Gomez, J.A., Nates, S., De Castagnaro, N.R., Espul, C., Borsa, A., and Glass, R.I. (1998). Anticipating rotavirus vaccines: Review of epidemiologic studies of rotavirus diarrhea in Argentina. Pan Am. J. Public Health 3, 69–78.CrossRefGoogle Scholar
  10. Greenough, A. (2001). Recent advances in the management and prophylaxis of respiratory syncytial virus infection. Acta Paediatr. Suppl. 90, 11–14.PubMedCrossRefGoogle Scholar
  11. Hall, A.J. (2001). Ecological studies and debate on rotavirus vaccine and intussusception. Lancet 358, 1197–1198.PubMedCrossRefGoogle Scholar
  12. Hemming, V.G., Prince, G.A., Groothuis, J.R., and Siber, G.R. (1995). Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections. Clin. Microbiol. Rev. 8, 22–33.PubMedGoogle Scholar
  13. Holberg, C.J., Wright, A.L., Martinez, F.D., Ray, C.G., Taussig, L.M., and Lebowitz, M.D. (1991). Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am. J. Epidemiol. 133(11), 1135–1151.PubMedGoogle Scholar
  14. Kirkwood, C.D. and Buttery, J. (2003). Rotavirus vaccines—An update. Expert. Opin. Biol. Ther. 3, 97–105.PubMedCrossRefGoogle Scholar
  15. Menon, S., Santosham, M., Reid, R., Almeido-Hill, J., Sack, R.B., and Comstock, G.W. (1990). Rotavirus diarrhoea in Apache children: A case-control study. Int. J. Epidemiol. 19, 715–721.PubMedCrossRefGoogle Scholar
  16. Midthun, K. and Kapikian, A.Z. (1996). Rotavirus vaccines: An overview. Clin. Microbiol. Rev. 9, 423–434.PubMedGoogle Scholar
  17. Murphy, B.R., Morens, D.M., Simonsen, L., Chanock, R.M., La Montagne, J.R., and Kapikian, A.Z. (2003). Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions. J. Infect. Dis. 187, 1301–1308.PubMedCrossRefGoogle Scholar
  18. Murphy, T.V., Garguillo, P.M., and Mehran, M.S. (2001). Intussusception among infants given an oral rotavirus vaccine. N. Engl. J. Med. 8, 564–572.CrossRefGoogle Scholar
  19. Murphy, T.V., Smith, P.J., Gargiullo, P.M., and Schwartz, B. (2003). The first rotavirus studies and intussusception: Epidemiological studies and policy decisions. J. Infect. Dis. 187, 1309–1313.PubMedCrossRefGoogle Scholar
  20. Naficy, A.B., Abu-Elyazeed, R., Holmes, J.L., Rao, M.R., Savarino, S.J., Kim, Y. et al. (1999). Epidemiology of rotavirus diarrhoea in Egyptian children and implications for disease control. Am. J. Epidemiol. 150, 770–777.PubMedCrossRefGoogle Scholar
  21. Nimri, L.F. and Hijazi, S. (1996). Rotavirus-associated diarrhoea in children in a refugee camp in Jordan. J. Diarrhoeal Dis. Res. 14, 1–4.PubMedGoogle Scholar
  22. Parashar, U.D., Bresee, J.S., Gentsch, J.R., and Glass, R.I. (1998). Rotavirus. Emerging Infect. Dis. 4, 561–570.PubMedCrossRefGoogle Scholar
  23. Parashar, U.D., Hummelman, E.G., Bresee, J.S., Miller, M.A., and Glass, R.I. (2003). Global illness and deaths caused by rotavirus disease in children. Emerging Infect. Dis. 9, 565–572.PubMedCrossRefGoogle Scholar
  24. Renneis, M.B. (2000). The rotavirus vaccine story: A clinical investigator’s view. Pediatrics 106, 123–125.CrossRefGoogle Scholar
  25. Simonsen, L., Morens, D., Elixhauser, A., Gerber, M., Van Raden, M., and Blackwelder, W. (2001). Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. Lancet 358, 1224–1229.PubMedCrossRefGoogle Scholar
  26. Velazquez, F.R., Matson, D.O., Calva, J.J., Guerrero, M.L., Morrow, A.L., Carter-Campbell, S. et al. (1996). Rotavirus infection in infants as protection against subsequent infections. N. Engl. J. Med. 335, 1022–1028.PubMedCrossRefGoogle Scholar
  27. Victoria, C., Bryce, J., Fontaine, O., and Monasch, R. (2000). Reducing deaths from diarrhoea through oral rehydration therapy. Bull. World Health Organization. 78, 1246–1255.Google Scholar
  28. Weijer, C. (2000). The future of research into rotavirus vaccine: Benefits of vaccine may outweigh risks for children in developing countries. Brit. Med. J. 321, 525–526.PubMedCrossRefGoogle Scholar
  29. World Health Organization. (1999). The evolution of diarrhoeal and acute respiratory disease control at WHO. WHO/CHS/CAH/99.12.Google Scholar
  30. World Health Organization. (2001). Report of the meeting on future directions for rotavirus vaccine research in developing countries, 9-11 February 2000, Geneva. WHOW&B/00.23.Google Scholar

Copyright information

© Science+Business Media New York 2004

Authors and Affiliations

  • Edward Kim Mulholland

There are no affiliations available

Personalised recommendations